Search
Categories
Hot topics close

Outlook Therapeutics shares surge on late-stage wet AMD bevacizumab study results

Outlook Therapeutics (OTLK) announces that its ONS-5010 / LYTENAVA (bevacizumab) treatment met the main and secondary goals in a late-stage study of patients with neovascular...
News Archive
  • 50 Cent
    50 Cent
    GTA 6 seemingly teased by 50 Cent
    3 Mar 2023
    2
  • Forza Horizon
    Forza Horizon
    Surprising No One, Forza Horizon 5 Is Awesome – Unlocked 515
    14 Oct 2021
    1
  • Guinness PRO14
    Guinness PRO14
    Pro14 final: Glasgow Warriors v Leinster - Build up from Celtic Park
    25 May 2019
    3
  • Gradient
    Gradient
    Gradient app: how to find out which celebrity you look like – and if the app is safe
    18 Oct 2019
    6
This week's most popular news